Laura M. Walker

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley et al. · The Lancet · 2020 · 2.6K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target

Laura M. Walker, Sanjay Phogat, Po-Ying Chan-Hui et al. · Science · 2009 · 1.7K citations

Life Sciences, Immunology, Infectious Diseases +17

Broad neutralization coverage of HIV by multiple highly potent antibodies

Laura M. Walker, Michael Huber, Katie J. Doores et al. · Nature · 2011 · 1.5K citations

Pharmacy, Immunology, Infectious Diseases +14

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

Jason S. McLellan, Marie Pancera, Chris Carrico et al. · Nature · 2011 · 849 citations · Full text

Life Sciences, Immunology, Molecular Biology +14